(Q41230892)

28 September 2017

1 reference

title

Adverse effects of bisphosphonates. A comparative review (English)

1 reference

28 September 2017

S Adami

1

1 reference

PubMed ID

8934578

28 September 2017

N Zamberlan

series ordinal

2

1 reference

28 September 2017

1 March 1996

1 reference

28 September 2017

1 reference

28 September 2017

14

1 reference

28 September 2017

3

1 reference

28 September 2017

158-170

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199614030-00003

28 September 2017

0 references

cites work

Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone

1 reference

12 December 2020

Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate

1 reference

12 December 2020

Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.

1 reference

12 December 2020

Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).

1 reference

12 December 2020

Long-lasting dermatological lesions after tiludronate therapy

1 reference

12 December 2020

Cytogenetic investigations of patients on clodronate therapy for Paget's disease of bone

1 reference

12 December 2020

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.

1 reference

12 December 2020

Dichloromethylene diphosphonate action in hematologic and other malignancies.

1 reference

12 December 2020

Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix

1 reference

12 December 2020

Multiple ulcerative esophagitis caused by alendronate

1 reference

12 December 2020

Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis

1 reference

12 December 2020

Tolerability and safety of clodronate therapy in bone diseases

1 reference

12 December 2020

Dichloromethylene diphosphonate (Cl2MDP) reduces natural killer (NK) cell activity in mice

1 reference

12 December 2020

Pamidronate associated hallucinations

1 reference

12 December 2020

Ototoxicity associated with intravenous bisphosphonate administration.

1 reference

12 December 2020

Effects of intravenous diphosphonates on renal function

1 reference

12 December 2020

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

12 December 2020

The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy

1 reference

12 December 2020

Acute intravenous infusion of disodium dihydrogen (1-hydroxyethylidene)diphosphonate: mechanism of toxicity.

1 reference

12 December 2020

Renal failure associated with intravenous diphosphonates

1 reference

12 December 2020

Lack of a T-cell dependent subpopulation of macrophages in (dichloromethylene) diphosphonate-treated mice

1 reference

12 December 2020

Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage

1 reference

12 December 2020

Effect of Disodium Ethane-l-Hydroxy-1, 1 - Diphosphonate on Bone Formation

1 reference

12 December 2020

Preliminary safety assessment of disodium etidronate as an additive to experimental oral hygiene products

1 reference

12 December 2020

Erythroderma after clodronate treatment

1 reference

12 December 2020

Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone

1 reference

12 December 2020

Renal handling of alendronate in rats. An uncharacterized renal transport system

1 reference

12 December 2020

Severe hypocalcaemia after treatment with oral clodronate and aminoglycoside

1 reference

12 December 2020

Pseudogout associated with the use of cyclical etidronate therapy

1 reference

12 December 2020

Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP)

1 reference

12 December 2020

Mineralisation defects with pamidronate therapy for Paget's disease

1 reference

12 December 2020

Cellular phosphate metabolism in patients receiving bisphosphonate therapy

1 reference

12 December 2020

Effects of two oral doses of alendronate in the treatment of Paget's disease of bone

1 reference

12 December 2020

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

1 reference

12 December 2020

Characterization of the early ultrastructural and biochemical events occurring in dichloromethane diphosphonate nephrotoxicity

1 reference

12 December 2020

Pamidronate disodium and possible ocular adverse drug reactions

1 reference

12 December 2020

Bisphosphonates and iritis

1 reference

12 December 2020

Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside

1 reference

12 December 2020

Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium

1 reference

12 December 2020

Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol

1 reference

12 December 2020

Uveitis associated with pamidronate

1 reference

12 December 2020

Severe reaction to diphosphonate: implications for treatment of Paget's disease

1 reference

12 December 2020

Bisphosphonates--history and experimental basis

1 reference

12 December 2020

The long-term skeletal effects of EHDP in dogs

1 reference

12 December 2020

Pamidronate: an unrecognized problem in gastrointestinal tolerability

1 reference

12 December 2020

Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.

1 reference

12 December 2020

The hyperphosphatemic effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP TM ): renal handling of phosphorus and the renal response to parathyroid hormone

1 reference

12 December 2020

The effect of alendronate on renal tubular reabsorption of phosphate

1 reference

12 December 2020

Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat

1 reference

12 December 2020

Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.

1 reference

12 December 2020

The acute-phase response after bisphosphonate administration

1 reference

12 December 2020

Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study

1 reference

12 December 2020

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

1 reference

12 December 2020

Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats

1 reference

12 December 2020

Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD), in rats and mice

1 reference

12 December 2020

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone

1 reference

12 December 2020

Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

1 reference

12 December 2020

Diphosphonates in Paget's disease

1 reference

12 December 2020

Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia

1 reference

12 December 2020

Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate

1 reference

12 December 2020

Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys

1 reference

12 December 2020

APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

1 reference

12 December 2020

The effects of disodium etidronate on the reproductive functions and embryogeny of albino rats and New Zealand rabbits

1 reference

12 December 2020

Clinical pharmacology of alendronate sodium

1 reference

12 December 2020

Reproduction toxicity studies with pamidronate

1 reference

12 December 2020

Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in rats

1 reference

12 December 2020

Effect of sodium etidronate in adult cats

1 reference

12 December 2020

The treatment of osteoporosis with disodium ethane-1, 1-diphosphonate

1 reference

12 December 2020

Effect of Ethane-l-hydroxy-l,l-diphosphonate (EHDP) and Dietary Fluoride on Biomechanical and Morphological Changes in Chick Bone

1 reference

12 December 2020

The short-term effects of high doses of ethylene-1-hydroxy-1, 1-diphosphonate upon early dentin formation

1 reference

12 December 2020

Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months

1 reference

12 December 2020

Treatment of hypercalcemia in osteolytic metastases with oral amino-hydroxypropylidene-diphosphonate

1 reference

12 December 2020

Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction

1 reference

12 December 2020

Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis

1 reference

12 December 2020

Renal transport of bisphosphonates: accumulation by renal cortical slices enhanced by calcium phosphate ions

1 reference

12 December 2020

Effect of clodronate on fracture healing in denervated rats

1 reference

12 December 2020

Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment

1 reference

12 December 2020

The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease

1 reference

12 December 2020

Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate

1 reference

12 December 2020

Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.

1 reference

12 December 2020

Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP)

1 reference

12 December 2020

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis

1 reference

12 December 2020

Osteoclasts, mononuclear phagocytes, and physiological bone resorption

1 reference

12 December 2020

Drug treatment of primary hyperparathyroidism: use of clodronate disodium

1 reference

12 December 2020

Metabolic requirement for inorganic phosphate by the rabbit proximal tubule

1 reference

12 December 2020

Effects of large doses of olpadronate (dimethyl-pamidronate) on mineral density, cross-sectional architecture, and mechanical properties of rat femurs

1 reference

12 December 2020

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

12 December 2020

Aseptic peritonitis in association with the use of pamidronate

1 reference

12 December 2020

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

1 reference

12 December 2020

Effects of the bisphosphonate, alendronate, on parturition in the rat

1 reference

12 December 2020

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

1 reference

12 December 2020

Renal secretion of diphosphonates in rats

1 reference

12 December 2020

Where do all the tablets go?

1 reference

12 December 2020

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

1 reference

12 December 2020

Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats

1 reference

12 December 2020

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

1 reference

12 December 2020

10.2165/00002018-199614030-00003

Identifiers

DOI

1 reference

PubMed ID

8934578

Dimensions Publication ID

28 September 2017

0 references

1 reference

PubMed ID

8934578